Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention …

Å Hjalmarson, S Goldstein, B Fagerberg, H Wedel… - Jama, 2000 - jamanetwork.com
the effects of controlled-release/extended-release metoprolol succinate (metoprolol CR/XL)
on mortality, as previously reported, 10 as well as hospitalizations, symptoms, and quality of …

Prognostic benefits of carvedilol, bisoprolol, and metoprolol controlled release/extended release in hemodialysis patients with heart failure: a 10‐year cohort

CH Tang, CC Wang, TH Chen, CY Hong… - Journal of the American …, 2016 - Am Heart Assoc
… ) has reported a reduction in allcause hospitalization and allcause mortality as a result of
the effects of 3 β‐blockers (carvedilol, bisoprolol, and metoprolol CR/XL) on mortality rates …

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

S Goldstein, B Fagerberg, Å Hjalmarson… - Journal of the American …, 2001 - jacc.org
the effect of the beta 1 -selective beta-blocker metoprolol succinate controlled release/…
CR/XL also decreased the combined end points of all-cause mortality or all-cause hospitalization (…

Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure

B Pasternak, H Svanström, M Melbye… - JAMA internal …, 2014 - jamanetwork.com
… of metoprolol succinate (controlled release/extended-release … than did metoprolol users;
assuming dose-dependent effects, … who died during index hospitalization and those with poor …

Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure

A Briasoulis, M Palla, L Afonso - The American journal of cardiology, 2015 - Elsevier
… carvedilol and metoprolol succinate in the cohort studies. In conclusion, in patients with
HFrEF, carvedilol and metoprolol succinate have similar effects in reducing all-cause mortality. …

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

C Torp-Pedersen, PA Poole-Wilson, K Swedberg… - American Heart …, 2005 - Elsevier
metoprolol-controlled release (CR) 8 on survival of patients with chronic stable heart failure.
Furthermore, both metoprolol … 1022 and 3196 first hospitalizations and total hospitalizations, …

Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy

DH Peters, P Benfield - Pharmacoeconomics, 1994 - Springer
… Nevertheless, these newer agents have no proven beneficial effect on mortality, and futher
studies are also warranted with controlled release metoprolol was cost saving over a 3-year …

Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure …

JK Ghali, IL Piña, SS Gottlieb, PC Deedwania… - Circulation, 2002 - Am Heart Assoc
… to evaluate the effect of metoprolol controlled-release/extended… end point of all-cause
mortality/all-cause hospitalizations (164 … LVEF to metoprolol succinate controlled-release/extended-…

Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study

XL Cheng, M Zhu, Q Liu, Z Feng… - … Design, Development and …, 2020 - Taylor & Francis
… In this study, we explored the effect of metoprolol on change … involving the effect of gender,
age, and metoprolol dose on … thus, long-term mortality and metoprolol influence on different …

Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy)

MH Ruwald, ACH Ruwald, C Jons, J Alexis… - Journal of the American …, 2013 - jacc.org
… of carvedilol and metoprolol succinate at the doses proven to reduce mortality remains to …
in hospitalizations for HF or death compared with metoprolol. A beneficial and synergistic effect